Home β€Ί Stock analysis β€Ί TRLV

Trulieve Cannabis (TRLV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

TRLV dips 2.8% to $10.01. Closed at $10.01, -2.82% vs the prior close of $10.30. Day range $9.81–$10.45, opened at $10.28.

Last close$10.01-2.82%
Day range9.81–10.45
Open10.28
Volume913.70K
52-week range4.62–13.28
Avg volume (20d)2.03M

TRLV daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” TRLV dips 2.8% to $10.01
Oct 15, 2026 β€” TRLV jumps 3.3% to $10.30
Oct 14, 2026 β€” TRLV dips 1.4% to $9.97, a 1-month low, 3 down days in a row
Oct 13, 2026 β€” TRLV dips 2.7% to $10.11, a 1-month low
Oct 12, 2026 β€” TRLV dips 2.6% to $10.39
Oct 9, 2026 β€” TRLV rises 2.9% to $10.67
Oct 8, 2026 β€” TRLV slides 3.8% to $10.37, a 1-month low
Oct 7, 2026 β€” TRLV rises 1.2% to $10.78
Oct 6, 2026 β€” TRLV ends flat (+0.0%) to $10.65, 5 down days in a row
Oct 5, 2026 β€” TRLV dips 0.7% to $10.65, a 1-month low, 4 down days in a row
Oct 2, 2026 β€” TRLV dips 1.4% to $10.72, a 1-month low, 3 down days in a row

TRLV latest news & SEC filings

Every SEC filing by or about TRLV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Aug 24, 2026 Β· Form S-8 POS β€” S-8 POS filing

S-8 POS filing

Source: SEC EDGAR filing 0001754195-26-000078

Aug 24, 2026 Β· Form POSASR β€” POSASR filing

POSASR filing

Source: SEC EDGAR filing 0001628280-26-058662

Aug 11, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001754195-26-000072

Aug 7, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001754195-26-000069

Aug 7, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001754195-26-000067

Aug 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001754195-26-000062

Jul 8, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000929638-26-002569

Jul 2, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001754195-26-000056

Jun 26, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-072664

Jun 25, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-072230

Jun 25, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001754195-26-000051

Jun 25, 2026 Β· Form DEFA14A β€” Additional proxy materials

Additional proxy materials

Source: SEC EDGAR filing 0001754195-26-000053

Jun 22, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-070732

Things to know before you trade TRLV

TRLV market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202610.2810.459.8110.01913.70K
Oct 15, 202610.0110.489.7910.301.42M
Oct 14, 202610.0710.509.909.971.73M
Oct 13, 202610.4210.4910.0610.11897.00K
Oct 12, 202610.6910.8710.3510.391.01M
Oct 9, 202610.3910.7410.1110.671.18M
Oct 8, 202610.7810.849.8710.371.50M
Oct 7, 202610.7010.9210.5510.782.01M
Oct 6, 202610.6810.8310.4210.651.16M
Oct 5, 202610.7010.8110.3910.651.90M
Oct 2, 202610.9611.3010.4010.722.27M
Oct 1, 202610.8711.2810.7010.872.55M
Sep 30, 202610.8611.1710.2210.908.37M
Sep 29, 202612.2912.5412.2212.411.72M
Sep 28, 202612.0912.8811.8812.341.49M
Sep 25, 202612.2512.4912.1112.211.01M
Sep 24, 202612.4112.5711.9412.271.73M
Sep 23, 202612.4012.9312.2612.542.99M
Sep 22, 202611.5012.4711.4312.473.25M
Sep 21, 202611.1911.8010.8511.501.58M

About Trulieve Cannabis

Trulieve Cannabis (TRLV) is listed on the NYSE and classified by the SEC under β€œMedicinal Chemicals & Botanical Products”. Its business address is in TALLAHASSEE, FL. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1754195.

TRLV board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Thad BeshearsDirectorMar 17, 2026
Matthew J. FoulstonDirectorMar 17, 2026
Peter HealyDirectorMar 17, 2026
Thomas L MillnerDirectorMar 17, 2026
Richard S. MayDirectorMar 17, 2026
Jane Cecil MorreauDirectorMar 17, 2026
Kim A. RiversChairman and CEOJun 26, 2026
Susan ThronsonDirectorMar 17, 2026

Executive officers

NameTitleLatest filing
Christine Ann HerseyChief Corp Affairs & StrategyMar 17, 2026
Nilyum JhalaChief Technology OfficerMar 17, 2026
Kyle LandrumChief Production OfficerMar 17, 2026
Joy MalivukChief Accounting OfficerDec 8, 2025
Timothy MoreyChief Sales OfficerDec 8, 2025
Jason PernellPresidentMar 17, 2026
Eric PowersChief Legal OfficerMar 17, 2026
Jan ReeseChief Financial OfficerMar 17, 2026
Kim A. RiversChairman and CEOJun 26, 2026
Brett R. WalshChief Accounting OfficerMar 17, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Jun 26, 2026Kim A. RiversSale136,811$8.76
Jun 26, 2026Kim A. RiversSale136,811$8.76
Jun 26, 2026Kim A. RiversSale136,811$8.76
Jun 26, 2026Kim A. RiversSale136,811$8.76
Jun 25, 2026Kim A. RiversSale300,000$8.17
Jun 25, 2026Kim A. RiversSale300,000$8.17
Jun 25, 2026Kim A. RiversSale300,000$8.17
Jun 25, 2026Kim A. RiversSale300,000$8.17
Jun 24, 2026Kim A. RiversSale400,000$8.17
Jun 24, 2026Kim A. RiversSale400,000$8.17
Jun 24, 2026Kim A. RiversSale400,000$8.17
Jun 24, 2026Kim A. RiversSale400,000$8.17
Jun 23, 2026Kim A. RiversSale380,000$8.47
Jun 23, 2026Kim A. RiversSale380,000$8.47
Jun 23, 2026Kim A. RiversSale380,000$8.47

TRLV financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$1.18Bβ€”-0.58$272.82M
Dec 31, 2024$1.19Bβ€”-0.79$271.48M
Dec 31, 2023$1.13Bβ€”-2.28$201.84M
Dec 31, 2022$1.22B$-252.73M-0.95$23.10M
Dec 31, 2021$931.93M$17.45M0.21$12.90M

Latest balance sheet: total assets $2.08B, total liabilities $1.31B, cash $325.42M (as of Jun 30, 2026).

TRLV earnings / results-day log

DateFilingClose that day
May 7, 20268-K Item 2.02 (results)$9.31
Feb 26, 20268-K Item 2.02 (results)$6.50
Nov 5, 20258-K Item 2.02 (results)$6.77
Aug 6, 20258-K Item 2.02 (results)$5.28
May 7, 20258-K Item 2.02 (results)$4.36
Feb 27, 20258-K Item 2.02 (results)$4.36
Nov 5, 20248-K Item 2.02 (results)$11.65
Aug 6, 20248-K Item 2.02 (results)β€”
May 9, 20248-K Item 2.02 (results)β€”
Feb 29, 20248-K Item 2.02 (results)β€”
Nov 9, 20238-K Item 2.02 (results)β€”
Aug 9, 20238-K Item 2.02 (results)β€”

Related stocks Β· Medicinal Chemicals & Botanical Products

Definium Therapeutics (DFTX)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)Sndl (SNDL)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on TRLV

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.